Business
CSL open to new manufacturing options after AstraZeneca production – Sydney Morning Herald
The biotech giant says it can hit the 50 million dose mark by December and is in talks with the government about how else it can help fight the pandemic.
Biotech giant CSL is in talks with the government about its longer-term role in Australias fight against coronavirus, as the company races to complete 50 million doses of the AstraZeneca vaccine by December.
The $123 billion blood plasma giant confirmed over the weekend that it was now producing more than 1 million doses of the vaccine per week, with more than 3.7 million doses released to the public by the end of April. There is a four-week quality control and approvals process that must be completed…
-
General21 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News21 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General23 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News23 hours agoUpdate: Attempted murder charges, Maroochydore